The vaccine could be a game-changer for people who have been holding out for another vaccine option.
, infectious disease expert at the University of Buffalo Jacobs School of Medicine and Biomedical Sciences, tells SELF. People who receive the Novavax vaccine—if cleared by the FDA and CDC—could still experience a breakthrough infection, meaning they could be infected with SARS-CoV-2, the coronavirus that causes COVID-19, even if fully vaccinated.
The Novavax vaccine is different than the Moderna and Pfizer-BioNTech vaccines in that it isn’t an mRNA vaccine. Nor is it a viral vector vaccine, as is the Janssen/Johnson & Johnson COVID-19 vaccine.
The way the Novavax vaccine is distributed and stored could also make a difference, Dr. Russo says. Unlike the Pfizer-BioNTech and Moderna vaccines, the Novavax vaccine doesn’t require specific cold storage. “It may improve access in certain rural parts of the country where cold storage is problematic, [such as] smaller community health centers that don’t have that capacity,” Dr. Russo says.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
What’s the difference between the Novavax vaccine and others? A doctor breaks it downNow that an FDA advisory committee has recommended the Novavax COVID-19 vaccination for emergency use, experts say we could possibly see the FDA give full approval of the vaccine soon.
Baca lebih lajut »
FDA advisers back Novavax COVID-19 vaccine as 4th option for US adultsA more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.
Baca lebih lajut »
FDA panel recommends Novavax COVID-19 vaccine be the fourth allowed for use in USThe vaccine, which was supported by $1.8 billion in taxpayer funding, uses a more traditional approach than some other COVID-19 vaccines allowed in the USA.
Baca lebih lajut »
What Would a Novavax Covid-19 Vaccine Mean in the US?FDA advisers overwhelmingly endorsed the vaccine, which Novavax hopes will sway holdouts to finally get their shots.
Baca lebih lajut »
FDA advisers greenlight Novavax COVID-19 vaccineA key U.S. FDA committee has recommended nearly unanimously that the agency grant an emergency authorization to a COVID19 vaccine from Novavax, opening the way for the first protein-based COVID-19 vaccine to become available to people in the U.S.
Baca lebih lajut »
Novavax’s Covid-19 Vaccine Backed by FDA AdvisersExperts advising the FDA endorsed Novavax’s Covid-19 vaccine, voting overwhelmingly that the shot’s benefits outweighed its risks. The agency is expected to next decide on authorizing the shot.
Baca lebih lajut »